Literature DB >> 19395857

Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling.

Hilary P Glazer1, Robert M Osipov, Richard T Clements, Frank W Sellke, Cesario Bianchi.   

Abstract

Nutritional excess and hyperlipidemia increase the heart's susceptibility to ischemic injury. Mammalian target of rapamycin (mTOR) controls the cellular response to nutritional status and may play a role in ischemic injury. To explore the effect of hypercholesterolemia on cardiac mTOR signaling, we assessed mTOR signaling in hypercholesterolemic swine (HC) that are also susceptible to increased cardiac ischemia-reperfusion injury. Yucatan pigs were fed a high-fat/high-cholesterol diet for 4 weeks to induce hypercholesterolemia, and mTOR signaling was measured by immunoblotting and immunofluorescence in the non-ischemic left ventricular area. Total myocardial mTOR and raptor levels were markedly increased in the HC group compared to the normocholesterolemic group, and directly correlated with serum cholesterol levels. mTOR exhibited intense perinuclear staining in myocytes only in the HC group. Hypercholesterolemia was associated with hyperactive signaling upstream and downstream of both mTOR complexes, including myocardial Akt, S6K1, 4EBP1, S6 and PKC-alpha, increased levels of cardiac hypertrophy markers, and a trend toward lower levels of myocardial autophagy. Hypercholesterolemia can now be added to the growing list of conditions associated with aberrant mTOR signaling. Hypercholesterolemia produces a unique profile of alterations in cardiac mTOR signaling, which is a potential target in cardiac diseases associated with hypercholesterolemia and nutritional excess.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395857      PMCID: PMC3308015          DOI: 10.4161/cc.8.11.8619

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  53 in total

Review 1.  Translational control of gene expression during hypoxia.

Authors:  Twan van den Beucken; Marianne Koritzinsky; Bradly G Wouters
Journal:  Cancer Biol Ther       Date:  2006-07-01       Impact factor: 4.742

2.  Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles.

Authors:  P Bruno; A Calastretti; M Priulla; L Asnaghi; F Scarlatti; A Nicolin; G Canti
Journal:  Cell Signal       Date:  2007-06-28       Impact factor: 4.315

3.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.

Authors:  Emilie Vander Haar; Seong-Il Lee; Sricharan Bandhakavi; Timothy J Griffin; Do-Hyung Kim
Journal:  Nat Cell Biol       Date:  2007-02-04       Impact factor: 28.824

4.  Increased Rheb-TOR signaling enhances sensitivity of the whole organism to oxidative stress.

Authors:  Parthive H Patel; Fuyuhiko Tamanoi
Journal:  J Cell Sci       Date:  2006-10-15       Impact factor: 5.285

5.  Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.

Authors:  Shakil Khan; Fadi Salloum; Anindita Das; Lei Xi; George W Vetrovec; Rakesh C Kukreja
Journal:  J Mol Cell Cardiol       Date:  2006-08       Impact factor: 5.000

6.  Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress.

Authors:  Munir Boodhwani; Yasunari Nakai; Shigetoshi Mieno; Pierre Voisine; Cesario Bianchi; Eugenio G Araujo; Jun Feng; Keith Michael; Jian Li; Frank W Sellke
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

Review 7.  Protein turnover in cardiac cell growth and survival.

Authors:  Nadia Hedhli; Michel Pelat; Christophe Depre
Journal:  Cardiovasc Res       Date:  2005-08-02       Impact factor: 10.787

8.  Activation of insulin-like growth factor signaling induces apoptotic cell death under prolonged hypoxia by enhancing endoplasmic reticulum stress response.

Authors:  Hiroko Endo; Kohei Murata; Mutsuko Mukai; Osamu Ishikawa; Masahiro Inoue
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

9.  FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle.

Authors:  Robert J Southgate; Bronwyn Neill; Oja Prelovsek; Assam El-Osta; Yasutomi Kamei; Shinji Miura; Osamu Ezaki; Thomas J McLoughlin; Wenwei Zhang; Terry G Unterman; Mark A Febbraio
Journal:  J Biol Chem       Date:  2007-05-17       Impact factor: 5.157

10.  Protein kinase C alpha modulates microvascular reactivity in the human coronary and skeletal microcirculation.

Authors:  Neel R Sodha; Jun Feng; Richard T Clements; Cesario Bianchi; Munir Boodhwani; Basel Ramlawi; Shigetoshi Mieno; Kamal R Khabbaz; Frank W Sellke
Journal:  Surgery       Date:  2007-08       Impact factor: 3.982

View more
  35 in total

1.  Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome.

Authors:  Sebastiano Sciarretta; Peiyong Zhai; Dan Shao; Yasuhiro Maejima; Jeffrey Robbins; Massimo Volpe; Gianluigi Condorelli; Junichi Sadoshima
Journal:  Circulation       Date:  2012-01-31       Impact factor: 29.690

2.  Methyl-beta-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt.

Authors:  Anne Kultti; Riikka Kärnä; Kirsi Rilla; Pertti Nurminen; Elina Koli; Katri M Makkonen; Jutong Si; Markku I Tammi; Raija H Tammi
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

3.  Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-alpha-dependent Akt activation in endosomes.

Authors:  Rafal Robert Nazarewicz; Gloria Salazar; Nikolay Patrushev; Alejandra San Martin; Lula Hilenski; Shiqin Xiong; R Wayne Alexander
Journal:  J Biol Chem       Date:  2010-11-20       Impact factor: 5.157

Review 4.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 5.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

Review 6.  mTOR complex 2 signaling and functions.

Authors:  Won Jun Oh; Estela Jacinto
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

Review 7.  Autophagy, myocardial protection, and the metabolic syndrome.

Authors:  Zoltan Giricz; Robert M Mentzer; Roberta A Gottlieb
Journal:  J Cardiovasc Pharmacol       Date:  2012-08       Impact factor: 3.105

8.  Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis.

Authors:  Zi-Lun Li; John R Woollard; Behzad Ebrahimi; John A Crane; Kyra L Jordan; Amir Lerman; Shen-Ming Wang; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

Review 9.  Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications.

Authors:  Mark J Czaja
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-20       Impact factor: 4.249

10.  Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2010-05       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.